Program Information
Dosimetric Impact of Beam Energy for Intrabeam Breast IORT with Different Residual Cancer Cell Distributions After Surgery
M Schwid , H Zhang*, Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, IL
Presentations
SU-E-T-327 (Sunday, July 12, 2015) 3:00 PM - 6:00 PM Room: Exhibit Hall
Purpose: The purpose of this study was to evaluate the dosimetric impact of beam energy to the IORT treatment of residual cancer cells with different cancer cell distributions after breast-conserving surgery.
Methods: The three dimensional (3D) radiation doses of IORT using a 4-cm spherical applicator at the energy of 40 keV and 50 keV were separately calculated at different depths of the postsurgical tumor bed. The modified linear quadratic model (MLQ) was used to estimate the radiobiological response of the tumor cells assuming different radio-sensitivities and density distributions. The impact of radiation was evaluated for two types of breast cancer cell lines (α/β=10, and α/β =3.8) at 20 Gy dose prescribed at the applicator surface. Cancer cell distributions in the postsurgical tissue field were assumed to be a Gaussian with the standard deviations of 0.5, 1 and 2 mm respectively, namely the cancer cell infiltrations of 1.5, 3, and 6 mm respectively. The surface cancer cell percentage was assumed to be 0.01%, 0.1%, 1% and 10% separately. The equivalent uniform doses (EUD) for all the scenarios were calculated.
Results: The EUDs were found to be dependent on the distributions of cancer cells, but independent of the cancer cell radio-sensitivities and the density at the surface. EUDs of 50 keV are 1% larger than that of 40 keV. For a prescription dose of 20 Gy, EUDs of 50 keV beam are 17.52, 16.21 and 13.14 Gy respectively for 0.5, 1.0 and 2.0 mm of the standard deviation of cancer cell Gaussian distributions.
Conclusion: The impact by selected energies of IORT beams is very minimal. When energy is changed from 50 keV to 40 keV, the EUDs are almost the same for the same cancer cell distribution. 40 keV can be safely used as an alternative of 50 keV beam in IORT.
Contact Email: